Entero Healthcare Solutions Stock Screener | Share Price & Fundamental Analysis
ENTERO
Pharmacy Retail
Screen Entero Healthcare Solutions share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1193.10
▲
80.60 (7.24%)
Share Price BSE
₹1194.45
▲
84.15 (7.58%)
Market Cap
₹4,532.53 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
2.53
EPS (TTM)
₹21.80
Dividend Yield
-
Debt to Equity
0.22
52W High
₹1549.55
52W Low
₹949.20
Operating Margin
4.00%
Profit Margin
2.35%
Revenue (TTM)
₹1,576.00
EBITDA
₹67.00
Net Income
₹37.00
Total Assets
₹2,703.00
Total Equity
₹1,770.00
Entero Healthcare Solutions Share Price History - Stock Screener Chart
Screen ENTERO historical share price movements with interactive charts. Analyze price trends and patterns.
Entero Healthcare Solutions Company Profile - Fundamental Screener
Screen Entero Healthcare Solutions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ENTERO shares.
Sector
Retail
Industry
Pharmacy Retail
Sub-Sector
Pharmacy Retail
Segment
E
ISIN
INE010601016
Entero Healthcare Solutions Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ENTERO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 2,703 | 2,345 | 1,309 | 1,126 | 836 | 749 |
| Current Assets | 2,076 | 2,011 | 1,023 | 851 | 636 | 552 |
| Fixed Assets | 559 | 289 | 268 | 262 | 189 | 186 |
| Liabilities | ||||||
| Total Liabilities | 2,703 | 2,345 | 1,309 | 1,126 | 836 | 749 |
| Current Liabilities | 87 | 102 | 87 | 101 | 58 | 56 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 1,770 | 1,641 | 598 | 563 | 487 | 424 |
| Share Capital | 44 | 44 | 4 | 4 | 517 | 439 |
| Reserves & Surplus | 1,676 | 1,593 | -73 | -62 | -32 | -16 |
Screen ENTERO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,576 | 1,410 | 1,346 | 1,367 | 1,312 | 1,111 | 1,043 | 994 | 998 | 901 | 888 | 832 |
| Expenses | 1,509 | 1,354 | 1,290 | 1,309 | 1,258 | 1,067 | 1,005 | 964 | 968 | 873 | 867 | 810 |
| EBITDA | 67 | 56 | 56 | 58 | 54 | 44 | 38 | 30 | 31 | 27 | 21 | 21 |
| Operating Profit % | 4.00% | 4.00% | 4.00% | 4.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 3.00% | 2.00% | 2.00% |
| Depreciation | 10 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 6 | 7 | 5 |
| Interest | 12 | 11 | 11 | 10 | 12 | 10 | 17 | 16 | 18 | 14 | 13 | 13 |
| Profit Before Tax | 45 | 36 | 37 | 39 | 35 | 27 | 14 | 8 | 7 | 7 | 1 | 3 |
| Tax | 8 | 6 | 6 | 10 | 9 | 7 | -8 | 1 | 2 | 0 | 5 | -1 |
| Net Profit | 37 | 30 | 31 | 30 | 26 | 21 | 21 | 7 | 5 | 6 | -4 | 4 |
| EPS | 7.26 | 6.39 | 5.91 | 5.85 | 5.43 | 4.62 | 5.73 | 4.21 | 3.24 | 15.18 | 1.49 | 8.67 |
Entero Healthcare Solutions Cash Flow Screener - Liquidity Fundamentals
Screen ENTERO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | -77 | -37 | -45 | -35 | -69 | -37 |
| Investing Activities | 232 | -704 | -49 | -162 | -31 | -203 |
| Financing Activities | -74 | 863 | 73 | 211 | 89 | 217 |
| Net Cash Flow | 82 | 122 | -21 | 14 | -11 | -23 |
Screen ENTERO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Feb | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 52.42% | 52.42% | 52.42% | 52.44% | 52.44% | 52.44% | 52.44% | 52.44% |
| FII Holding | 19.92% | 17.20% | 14.67% | 0.00% | 23.30% | 23.32% | 23.82% | 22.21% |
| DII Holding | 9.64% | 10.18% | 9.65% | 1.36% | 2.28% | 2.06% | 7.73% | 8.77% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.41% | 6.99% | 9.36% | 5.72% | 4.95% | 5.00% | 4.06% | 4.36% |
| Other Holding | 12.61% | 13.20% | 13.90% | 40.48% | 17.03% | 17.18% | 11.95% | 12.23% |
| Shareholder Count | 33,159 | 33,338 | 36,334 | 58 | 80,864 | 66,400 | 36,767 | 33,172 |
Entero Healthcare Solutions Dividend Screener - Share Yield Analysis
Screen ENTERO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Entero Healthcare Solutions Index Membership - Market Screener Classification
Screen ENTERO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Entero Healthcare Solutions Market Events Screener - Corporate Actions
Screen ENTERO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -2.28% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -2.01% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -0.69% |
| 2025-05-27 | 2025-05-27 | Quarterly Result Announcement | NA | 2.33% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -3.18% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 6.49% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 4.51% |
Entero Healthcare Solutions Competitors Screener - Peer Comparison
Screen ENTERO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Medplus Health Services | 9,707 | 49.52 | 6,185 | 9.18% | 150 | 50.68 |
| Entero Healthcare Solutions | 4,533 | 34.95 | 5,135 | 30.45% | 107 | 54.23 |
| Vijaypd Ceutical | 83 | 17.09 | 118 | 99.16% | 5 | 40.64 |
| Trimurthi | 59 | 9 | -4.17% | -2 | 55.70 |
Entero Healthcare Solutions Company Announcements - News Screener
Screen ENTERO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-07 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-06 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-06 | Intimation For Grant Of 73060Options Pursuant To "Entero Employees Stock Options Plan 2023" To The Eligible Employees Of The Company | View |
| 2025-12-04 | Announcement under Regulation 30 (LODR)-Credit Rating | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-20 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Acquisition | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | View |
| 2025-11-12 | Submission Of Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Dated November 12 2025 | View |
| 2025-11-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-29 | Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended September 30 2025 | View |
| 2025-10-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |